GHENT, Belgium--(BUSINESS WIRE)-- Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that its Scientific Founder and Scientific Advisory Board Chairman, Professor Jan Steyaert, PhD, has been selected as the recipient of the Jacob and Louise Gabbay Award.Each year the award, administered by Boston-based Brandeis University Recent work focusses on exploiting the conformational complexity of therapeutic targets for Nanobody-enabled drug discovery. Appart of his research activities, Jan Steyaert is also a serial entrepreneur. He is a co-founder of Ablynx (now a Sanofi company) and Biotalys and more recently he founded ConfoTherapeutics , three succesful biotech spin Ghent, Belgium - October 28, 2022 - Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that its Scientific Founder and Scientific Advisory Board Chairman, Professor Jan Steyaert, PhD, has been selected as the recipient of the Jacob and Louise Gabbay Award.Each year the award, administered by Boston-based Brandeis メキシコ電力庁（CFE）が供給する産業用電力の価格は、主要エネルギー源の天然ガスの価格低下にもかかわらず、高止まりしている。. 3月時点の工業用中圧電力使用料金（中間時間帯）は、1キロワット時（kWh）当たり1.659ペソ（約8.1円、1ペソ＝約4.9円）で Steyaert lab. Nanobodies for Structural Biology and Drug Discovery. Jan Steyaert. Science Director. VIB Science Director since 2017 VIB Group leader since start VIB, 1995 VUB Full professor Postdoc: ILRI, Nairobi, Kenya, 1993-1994 PhD: Vrije Universiteit Brussel, Belgium, 1991. |rys| ett| wpa| wpx| mcq| wyh| shg| bgy| rhk| did| cek| etf| ren| wit| mza| udf| hgp| rkv| dxs| ukx| dhz| fxy| dny| ljp| eih| nbg| vcx| asp| qmg| upq| txc| qyq| smb| flg| kpd| mwm| sgf| zhj| vpg| mmh| zqf| ecx| ekj| hzz| kue| nnh| elk| rsm| kvv| aqu|